Intravenous chemotherapy for children at home
Intended for healthcare professionals
Clinical Previous     Next

Intravenous chemotherapy for children at home

Jacqueline Edwards Clinical Nurse Specialist
Maggie Breen Specialist Sister, Royal Marsden Hospital, Sutton, Surrey

It is becoming common practice for children with acute lymphoblastic leukaemia to receive the chemotherapy agent intravenous cytosine arabinoside (cytarabine, ara C), within the home. This practice is enabled by paediatric oncology outreach nurses based in a regional children’s cancer centre and is administered by children’s community nursing teams. This article discusses the role, development and audit of clinical practice guidelines relating to this work. An audit has found the guidelines to be a useful tool to inform clinical practice.

Cancer Nursing Practice. 1, 5, 26-29. doi: 10.7748/cnp2002.06.1.5.26.c36

Peer review

This article has been subject to double blind peer review

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or